<DOC>
	<DOC>NCT00532766</DOC>
	<brief_summary>To evaluate the pharmacokinetic and pharmacodynamic profile of a new human insulin (Jusline) after subcutaneous administration, and to compare this profile with Humulin insulin.</brief_summary>
	<brief_title>Evaluating Pharmacokinetics and Pharmacodynamics of Jusline</brief_title>
	<detailed_description>To study the pharmacokinetic and pharmacodynamic profile of a new human insulin (Jusline) after subcutaneous administration in the abdominal, and to compare this profile with Humulin insulin for three different preparations (Regular, NPH, and Premixed Regular/NPH (30/70)).</detailed_description>
	<criteria>Healthy Nondiabetic Age 1835 year Normal body mass index (BMI 1825 kg/m2) Diabetics Overweight/obese Anemic, with liver, cardiac, renal or thyroid dysfunction</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Healthy subjects</keyword>
</DOC>